day 1 agenda

5th Edition of Innovations and State of the Art in
ALZHEIMER'S & DEMENTIA
Sep 12 - 13, 2024 at Lisbon, Portugal
Tentative Program
Day -1: September (12, 2024)
Meeting Hall - 1
Registrations Open 08:00-08:45
Opening Ceremony 08:45-09:00
Keynote Talks
09:00-09:30 Title: Brain Hydrophobic Peptides Antagonists of Neurotoxic Amyloid β Peptide Monomers/Oligomers-Protein Interactions
Carlos Gutierrez-Merino, University of Extremadura, Spain
09:30-10:00 Title: Epigenetic Dysregulation of Cholesterol Biosynthesis Gene Expression in Alzheimer’s Disease: Implications in Therapy
Tapas K Kundu, JNCASR, India
10:00-10:30 Title: Efficacy of cognitive-behavioral therapy-based intervention on type 2 diabetes patients with comorbid metabolic syndrome: a randomized controlled trial
Jing Sun, Charles Sturt University, Australia
Group Photo & Refreshment Break (10:30-10:50)
Technical session-I
  THEMES: Alzheimer’s Research and Therapy,
Advances in Alzheimer’s and Dementia Research
10:50-11:10 Title: Towards a unitary hypothesis of Alzheimer disease pathogenesis
Eric A. Schon, Columbia University, USA
11:10-11:30 Title:Alzheimer’s Disease, the Blood-Brain Barrier, and Vascular Dysfunction: Linking Amyloid-Beta to Vascular Pathology
Giorgia Caspani, University of British Columbia, Canada
11:30-11:50 Title:Neuroprotective effects of a new NMDA receptor antagonist in Alzheimer's Disease
Aline Freyssin, ReST therapeutics, France
11:50-12:10 Title: AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer’s disease
Yury Miller, UCSD, USA
12:10-12:30 Title:Cell-free chromatin particles released from dying cells inflict mitochondrial damage and ROS production in living cells: implications for Alzheimer’s disease and Dementia
Indraneel Mittra, Tata Memorial Centre, India
12:30-12:50                      SPEAKER SLOT AVAILABLE
Lunch Break @ Restaurant (12:50-14:00)
Technical Session-II
  THEMES: Dementia diagnosis, treatment, &
Aging and Dementia
14:00-14:20 Title: Understanding the etiology of dementia: Role of Non-Demented Alzheimer Neuropathology (NDAN) Subjects
Paul L Wood, Lincoln Memorial University, USA
14:20-14:40 Title:Breakthrough Research in Reversing Brain Aging
Judy Qiao, Royavita Biotech, USA
14:40-15:00 Title: Neuroprotective Effects of Asparagus Officinalis Stem Extract in Transgenic Mice Overexpressing APP
Marie-Francoise Joelle Doursout, McGovern Medical School, University of Texas Health Science Center at Houston, USA
15:00-15:20 Title:  PDE5 inhibitors against synaptic and cognitive impairment in Alzheimer’s disease and related dementia
Ottavio Arancio , Columbia University, USA
15:20-15:40                      SPEAKER SLOT AVAILABLE
15:40-16:00 Title: TBA
Arushi Kapoor, University of Pennsylvania, USA
Refreshment Break (16:00-16:20)
16:20-16:40 Title:Electrovestibulography as a physiological monitoring tool for tACS treatment in dementia
Brian Lithgow, University of Manitoba, Canada
16:40-17:00 Title: Whole Genome Deconvolution Unveils Alzheimer’s Resilient Epigenetic Signature
Eloise Berson,Stanford University ,USA
17:00-17:20 Title: Engagement with People with Dementia, their Care Partners with Participatory Action Research Facilitating Hospital-to-Home Care Transitions
Ann MacLeod,Trent Fleming School of Nursing, Canada
17:20-17:40 Title:Longitudinal non-pharmaceutical treatment of a patient with Alzheimer’s disease: a case study
Zahra Moussavi, University of Manitoba, Canada
17:40-18:00 Title:Using Natural Language Processing to identify social determinants of Health and dementia from Electronic Health Records
Elham Mahmoudi, University of Michigan, USA
Day-1 Concludes
Note: We are still accepting abstracts and the tentative program will be updated 
If any one interested to attend the conference or to book your speaker slot, please send an email to dementiacongress@innovinc.org

day 2 agenda

Tentative Program
Day -2: September (13, 2024)
Meeting Hall - 1
Registrations Open 08:00-08:45
Opening Ceremony 08:45-09:00
Keynote Talks
09:00-09:30 Title: Blood-brain barrier role in cognitive impairment and Alzheimer’s’ disease and therapeutic opportunities
Berislav Zlokovic, University Of Southern California, USA
09:30-10:00 Title: Cognitive Performance in Asymptomatic Elderly People with Hepatitis C: The Role of Education
Sergio L. Schmidt, Federal University of the State of Rio de Janeiro, Brazil
10:00-10:30 Title: Alzheimer’s Disease: A Review of Pathology, Current Treatments, and the Potential Therapeutic Effect of Decreasing Oxidative Stress by increasing glutathione levels with Combined Vitamin D and L-Cysteine Supplementation
Sushil K Jain, Louisiana State University Health Sciences Center,USA
Refreshment Break (10:30-10:50)
Technical session-III
  THEMES: Molecular and cell Biology,
Neurodegenerative Diseases
10:50-11:10 Title:The role of NEDD4 family members in neurodegenerative diseases
Edgar R. Kramer, University of Plymouth, Germany
11:10-11:30 Title: Blood Brain Barrier (BBB): The Nexus of Neurodegenerative Dementia
Charles R Joseph, Liberty University College of Osteopathic Medicine, USA
11:30-11:50 SPEAKER SLOT AVAILABLE
11:50-12:10 Title: Amyloid fibril formation mechanism and dynamic membrane interaction of human calcitonin and glucagon
Akira Naito, Yokohama National University, Japan
12:10-12:30 Title:Cross-Seeding Mechanism for Modulating Amyloid Features by Antimicrobial Peptides
Jie Zheng, University of Akron, USA
12:30-12:50 Title:Identification of Intron Retention in the Slc16a3 Gene Transcript Encoding the Transporter MCT4 in the Brain of Aged and Alzheimer-Disease Model (APPswePS1dE9) Mice
LADEVEZE, Université de Poitiers, France
Lunch Break @ Restaurant (12:50-14:00)
Technical Session-IV
  THEMES: Dementia care research and Practice,
Case Studies, & Amyloid and Tau Protein
14:00-14:20 Title:Hospital Readmission and Frequent Hospitalizations among Patients with dementia in the U.S
Elham Mahmoudi, University of Michigan, USA
14:20-14:40 Title:Meningitis in the guise of dementia: Lyme-induced normal pressure hydrocephalus
Ryan Liu, Cooper University Health Care, USA
14:40-15:00 Title: Learning cued interval timing, the role of acetylcholine, and the impact of amyloidosis
Marshall G Hussain Shuler, Johns Hopkins University, USA
15:00-15:20 Title: Examining the intersection of cognitive and physical function measures in the brain networks and mobility (B-NET) study
Atalie Carina Thompson,Wake Forest Baptist Health,USA
15:20-15:40 Title: Astroglia as a key player in the pathology of Alzheimer´s Disease and other Dementias
J. J. Rodríguez, IKERBASQUE, Spain
15:40-16:00 SPEAKER SLOT AVAILABLE
Refreshment Break (16:00-16:20)
  Poster Presentations
PP-1 Title: The effectiveness of Kami Guibi-tang for cognitive impairment patients: A retrospective chart review
Dong-Joo Kim, Kyung Hee University Hospital at Gangdong, South Korea
PP-2 Title: Towards a unitary hypothesis of Alzheimer disease pathogenesis
Eric A. Schon, Columbia University, USA
PP-3 SLOT AVAILABLE
Day-2 Concludes
Note: We are still accepting abstracts and the tentative program will be updated 
If any one interested to attend the conference or to book your speaker slot, please send an email to dementiacongress@innovinc.org

posters agenda

  Poster Presentations
PP-1 Title: The effectiveness of Kami Guibi-tang for cognitive impairment patients: A retrospective chart review
Dong-Joo Kim, Kyung Hee University Hospital at Gangdong, South Korea
PP-2 Title: Towards a unitary hypothesis of Alzheimer disease pathogenesis
Eric A. Schon, Columbia University, USA
PP-3 SLOT AVAILABLE
Note: We are still accepting abstracts and the tentative program will be updated 

posters agenda

Tentative Program
Day -1: September (12, 2024)
Virtual Program(Lisbon Time)
09:00-09:20 Title: Brain injury and prison: over-representation, prevention and reform
Molly Townes O'Brien , Australian National University, Australia
09:20-09:40 Title: Gut microbiota may be involved in Alzheimers disease pathology by dysregulating pyrimidine metabolism in APP/PS1 mice
Yingjun Zhang, Hunan University of Medicine, China
09:40-10:00 Title: Increased expression of protein O-linked mannose beta-1,2-N-acetylglucosaminyltransferase 1 ameliorates Alzheimer's disease-like pathologies in its cell and mouse models
Xiaofeng Li, Chongqing Medical University, China
10:00-10:30 Keynote Talk: Future Treatment of Alzheimer’s Disease; Why Multi-Target Drugs
Moussa B.H.Youdim, Technion-Israel Institute of Technology, Isarel
10:30-10:50 Title: Immunological markers of mixed dementia      
Elina Reznik , Immanuel Kant Baltic Federal University, Russia
10:50-11:10 Speaker Slot Available
11:10-11:30 Title:  Increased telomerase improves motor function and alpha_synuclein pathology in a transgenic mouse model of Parkinson’s disease associated with enhanced autophagy
Gabriele Saretzki, Newcastle University, UK
11:30-11:50 Title: Closed-loop acoustic stimulation in mice
Lisa Marshall, University of Lübeck, UKSH, Germany
11:50-12:10 Speaker Slot Available
12:10-12:30 Title:  Self-esteem, positive affect and agreeableness in the relationship between parental educational practices and life satisfaction in adolescence
Nieves Fátima Oropesa Ruiz , Almería, Spain
12:30-12:50 Title: Assessment of social referencing – the development of the Social Referencing Observation Scale as a Screening Instrument for ASD
Anna Lubomirska, Institute for Child Development, Poland
12:50-13:10 Title:  A Practical Guide to Culturally Informed Neuropsychological Evaluations in Children with Epilepsy
Gretchen Berrios-Siervo , University of Colorado School of Medicine, USA
13:10-13:30 Title: Religious and spiritual struggle and its connection with depression and anxiety
Salvador Leavitt-Alcantara, Cincinnati Children's Hosp Med Ctr - Cincinnati, OH, USA
13:30-13:50 Title: Comparing Stem Cells, Transdifferentiation and Brain Organoids as tools for Psychiatric Research
Alfredo Bellon, Penn State Milton S. Hershey Medical Center, USA
13:50-14:10 Title: Nontraditional Post-Baccalaureate Students: How to Better Provide Support for Perceived Mental Health Needs
Elizabeth Alderton & Renae Swanson, University of Wisconsin Oshkosh, USA
14:10-14:30 Title: Characterization of an Lmx1a-dependent gene network that regulates hippocampal development
Victor Chizhikov, University of Tennessee Health Science Center, USA
14:30-14:50 Speaker Slot Available
14:50-15:10 Title: Amyloid b Ion Channels in Alzheimer’s Disease
Suren Tatulian, University of Central Florida, USA
15:10-15:40 Keynote Talk: Novel synaptic protective lipid mediators in Alzheimers disease
Nicolas G. Bazan, Louisiana State University Health New Orleans, USA
15:40-16:00 Title: Association of region-specific hippocampal reduction of neurogranin with inflammasome proteins in post-mortem brains of Alzheimer’s disease
REGINA Vontell, University of Miami, USA
16:00-16:20 Title: Brain N-acetyl-aspartyl-glutamate (NAAG) is associated with cognitive function in virally-suppressed people living with HIV
Robyn Wiseman, Johns Hopkins University School of Medicine,USA
16:20-16:40 Speaker Slot Available
Day-1 Concludes
Day -2: September (13, 2024)
Virtual Program(Lisbon Time)
09:00-09:20 Title: Mortality, revascularization and cardioprotective pharmacotherapy after acute coronary syndrome in patients with severe mental illness: a systematic review and meta-analysis
Wing Chung Chang, University of Hong Kong, Hong Khong
09:20-09:40 Speaker Slot Available
09:40-10:00 Title: Deciphering Anti_Alzheimer Drug Candidate Mechanism of Action Using a Bioorthogonal Chemistry-derived Pharmacophore Strategy
Nicolas SERGEANT, Inserm Nord-Ouest, France
10:00-10:30 Keynote Talk: Aminopeptidase A and Dipeptidyl aminopeptidase 4 contribute to early lesions in Alzheimer’s disease
Checler Frederic, University of Nice-Sophia-Antipolis, France
10:30-10:50 Title: Catching the threads: caregiving in Alzheimer's disease 
Elizabeth Kuipers , IOPPN, King’s College London, UK
10:50-11:10 Speaker Slot Available
11:10-11:30 Title: Bioinformatic Analysis of Diverse Amyloids
 Marcel Zamocky, Slovak Academy of Sciences, slovakia
11:30-11:50 Title: Spike Timing-Dependent Plasticity and brain oscillations in Alzheimer's disease: Dissecting the earliest time point of hippocampal functional impairment during the disease progression
Yuniesky Andrade-Talavera, University Pablo de Olavide, Spain
11:50-12:10 Speaker Slot Available
12:10-12:30 Title:  Advance Directives: Knowledge of the Topic Among Psychiatrists
 Vania Novelli Domingues & Monica Domingues Monteiro, University of Porto, Portugal
12:30-12:50 Speaker Slot Available
12:50-13:10 Title:THE CPT-2 CASCADE HYPOTHESIS FOR ALZHEIMER'S DISEASE
Hiskias G.Keizer, Alloksys/AMRIF, The Netherlands 
13:10-13:30 Speaker Slot Available
13:30-13:50 Title: Inhibition of TrkB receptor impairs exercise_induced attenuation of cocaine-seeking behavior
Marian T Sepulveda-Orengo,Ponce Health Sciences University, USA
13:50-14:10 Title: Transformative Advances in Alzheimers Disease Diagnosis: Harnessing the Power of Generative AI for Early Detection and Research Advancements
Surabhi Sinha, Adobe, USA
14:10-14:30 Speaker Slot Available
14:30-14:50 Title:Deleterious effects of amyloid_beta oligomers on memory and sleep in Alzheimer’s disease
Jonathan Brouillette, University of Montreal, Canada
14:50-15:10 Title: Nontraditional Post-Baccalaureate Students: How to Better Provide Support for Perceived Mental Health Needs
Elizabeth Alderton & Renae Swanson, University of Wisconsin Oshkosh, USA
15:10-15:40 Title: Sex-specific impairment of amygdala-dependent associate memory and long-term potentiation in the basolateral amygdala following global cerebral ischemia
Jose Vigil, University of Colorado Anschutz Medical Campus, USA
15:40-16:00 Title: Impact of social media addiction on college students’ academic performance
Weihong Ning, Central Connecticut State University, USA
16:00-16:20 Speaker Slot Available
Day-2 Concludes
Note: This is the tentative program only and the program will be updated 

Download